Who knew? A meek open with flat futures turns into a powerful rally with a 4-to-1 advance/decline ratio and most industry groups participating.
FDX Federal Express, and MS Morgan Stanley, lead the charge. Even Darden Restaurants DRI (chart) with earnings right at estimates gets a nice bump up. AMLN Amlin Pharma gets an upgrade and is higher. The chart looks nice, the back story is that they can't make enough of their new diabetes drug to meet the enormous demand. The stock fell in the short run on this news, but in the long run this is bullish news. The stock is a tough one to evaluate because it is $5 billion, but still considered a developmental/research company.
No comments:
Post a Comment